Login / Signup

Bisphosphonates Maintain BMD after Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis.

Mafo Kamanda-KossehStephanie ShiauSanchita AgarwalAnanya KondapalliIvelisse ColonNayoung KilMariana BucovskyJoan M LappeJulie StubbyElizabeth ShaneAdi Cohen
Published in: The Journal of clinical endocrinology and metabolism (2024)
BMD remained stable in women with PremenIOP who received bisphosphonates after sequential teriparatide-denosumab therapy.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • body composition
  • mesenchymal stem cells
  • giant cell